Custom Orthoses for Leg Injuries
(CDODistract Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how custom-made leg braces (CDOs), crafted from carbon fiber, affect walking and comfort for individuals with leg injuries. Researchers aim to determine if varying the height between the heel and the brace’s footplate alters weight distribution on the foot. Participants will walk with and without these braces at different heel heights. The trial seeks individuals who have experienced a traumatic hindfoot injury and suffer mechanical pain when bearing weight on their leg. As an unphased trial, it offers participants the chance to contribute to innovative research that could enhance mobility solutions for future patients.
Do I have to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that these orthoses are safe for use in leg injuries?
Studies have shown that custom braces made from carbon fiber, known as dynamic orthoses (CDOs), can enhance walking and leg function after lower leg injuries. These braces reduce stress on joints, potentially lowering the risk of arthritis. Although specific safety data is not available, specialized centers use CDOs, indicating they are generally safe for many patients. The trial tests different heel heights (0cm, 1cm, and 2cm) to assess brace fit, and these variations do not introduce new safety concerns. Overall, CDOs are well-tolerated, with no reports of serious side effects.12345
Why are researchers excited about this trial?
Researchers are excited about the Carbon Fiber Custom Dynamic Orthosis (CDO) because it offers a personalized approach to managing leg injuries. Unlike traditional orthoses, which are often generic and inflexible, the CDO's carbon fiber construction allows for a lightweight and dynamic fit, potentially improving mobility and comfort. By experimenting with different heel distraction heights (0cm, 1cm, and 2cm), this treatment aims to optimize support and functionality tailored to individual needs, which could lead to better rehabilitation outcomes compared to standard options.
What evidence suggests that these orthoses could be effective for leg injuries?
Research has shown that Carbon Fiber Custom Dynamic Orthoses (CDOs) can reduce pain and improve leg support. Studies have found that CDOs lower pressure on the front part of the foot compared to walking without support, spreading pressure more evenly and making walking more comfortable. Additionally, CDOs distribute forces around the leg, supporting overall leg function and aiding recovery from injuries. In this trial, participants will be assigned to different groups to test the effectiveness of CDOs with varying heel distraction heights or without a CDO, evaluating their impact on leg injuries. These benefits suggest that CDOs might be a good option for people with leg injuries who want to reduce pain and move more easily.13678
Who Is on the Research Team?
Jason M Wilken, PT, PhD
Principal Investigator
University of Iowa
Are You a Good Fit for This Trial?
This trial is for individuals aged 18-50 with a unilateral leg injury or disease affecting muscles, bones, or nerves. Participants must use a carbon fiber custom dynamic orthosis (CDO), experience mechanical pain when loading the limb (>4/10 on pain scale), walk 50 feet at a slow to moderate pace without support, and be able to read/write in English.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants undergo baseline assessments including pain rating and gait analysis without orthoses
Treatment
Participants complete study activities with different heel distraction heights using CDOs
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Carbon Fiber Custom Dynamic Orthosis (CDO)
Carbon Fiber Custom Dynamic Orthosis (CDO) is already approved in United States, European Union, Canada for the following indications:
- Foot drop
- Plantar flexion weakness
- Ankle instability
- Neurological conditions affecting the lower limbs
- Foot drop
- Plantar flexion weakness
- Ankle instability
- Neurological conditions affecting the lower limbs
- Foot drop
- Plantar flexion weakness
- Ankle instability
- Neurological conditions affecting the lower limbs
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Iowa
Lead Sponsor
Fabtech Systems
Collaborator